• December 1, 2011
  • 6th Annual International Translational Medicine Symposium Held at Penn

  • Discussions on personalized genomics and disease risk, epigenetics, and drug development models that work

PHILADELPHIA – A unique gathering of international experts will be charting the unfolding landscape of how to bring personalized medicines to the consumer. Thought leaders from academic medical centers, government, and industry will identify opportunities and hazards about using personal genomic information to develop new treatments and cures. Held at the Perelman School of Medicine at the University of Pennsylvania on October 18 and 19, the 6th Annual Institute for Translational Medicine and Therapeutics (ITMAT) International Symposium, Translational Strategies in Contemporary Science, brings together a distinguished faculty of over two dozen international thought leaders who will discuss the present and future of translational medicine, including personalized genomics and disease risk; nature vs. nurture and epigenetics in personalized medicine; and recent drug-development models that work.

WHAT: Talks will cover:
The promise of how personal genomes can lead to better drug response and disease-risk assessment and how environmental factors such as diet limit that promise.

Innovative approaches of academic-based research that are upending large Pharma’s traditional role as the primary developer of new drugs.

A new collaborative model of drug discovery that is moving away from a single, private company to teams built from academia and the pharmaceutical and biotech industries.

WHO: Garret A. FitzGerald, MD, Robert L. McNeil, Jr., Professor of Translational Medicine and Therapeutics, Chair of Department of Pharmacology, Director of ITMAT and Perelman School of Medicine, University of Pennsylvania (Conference Organizer)

Over 30 thought leaders in translational medicine will participate as speakers and panelists.

Among the Highlights…


Day 1

As access to personal genomic information becomes more widespread, is there more to understanding disease risk and response than simply knowing your genome? Hear from speakers with two different perspectives on this issue:

Isaac S. Kohane, MD, PhD, Lawrence J. Henderson Professor of Health Sciences and Technology, Director of the Countway Library of Medicine, Co-Director of the Center for Biomedical Informatics, Harvard Medical School; and Director, i2b2 National Center for Biomedical Computing - Overcoming the Incidentalome for a Responsible Genomic Medicine

Jun Wang, PhD, Executive Director of BGI (formerly known as Beijing Genomics Institute)  - Sequencing, Sequencing and Sequencing

Jeremy K. Nicholson, PhD, FRSC, FRCPath, FMedSci, Head of Department of Surgery and Cancer, Imperial College London, UK - Systems Medicine and Patient Journey Phenotyping

Day 2

What happens when genome meets environment? Learn more about the landscape that is so critical for the progression of personalized medicine:

Shelley L. Berger, PhD, Daniel S. Och University Professor, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania - The Epigenetic Regulation of the Genome

Day 2

How can we fix the current drug development crisis? And what role can academia play? Learn about the traditional and new academic models for drug development from the people who have made them work:

Carl June, MD, Professor of Pathology and Laboratory Medicine, and Program Director for Translational Research in the Abramson Family Cancer Research Institute - Synthetic Biology with Engineered T Cells

Joseph Schlessinger, PhD, William H. Prusoff Professor and Chair of Pharmacology, Yale University School of Medicine - Cell Signaling by Receptor Tyrosine Kinases; from Basic Principles to Cancer Therapy

Peter J. Ratcliffe, MD, FRCP, FMedSci, FRS, Nuffield Professor of Medicine and Head of Department, Nuffield Department of Clinical Medicine, University of Oxford - Drug Target Discovery in Academia

WHERE: Perelman School of Medicine, University of Pennsylvania
Biomedical Research Building II/III
Auditorium and Lobby
421 Curie Boulevard, Philadelphia, PA 19104
WHEN: Tuesday and Wednesday, October 18-19, 2011

 

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.

 

 

Print, Share, or Save
 
Media Contact

Karen Kreeger
(215)349-5658

 
Other Contacts
 
 
Latest News
All News Releases


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2013, The Trustees of the University of Pennsylvania